Magnesium Sulfate and Potassium Sulfate and Sodium Sulfate
Brand names: Suflave · Active ingredient: Magnesium Sulfate Anhydrous
In short: SUFLAVE is indicated for the cleansing of the colon as a preparation for colonoscopy in adults.
What is Magnesium Sulfate and Potassium Sulfate and Sodium Sulfate used for?
SUFLAVE is indicated for the cleansing of the colon as a preparation for colonoscopy in adults.
Magnesium Sulfate and Potassium Sulfate and Sodium Sulfate dosage
Correct fluid and electrolyte abnormalities before treatment with SUFLAVE
Two doses of SUFLAVE are required for a complete preparation for colonoscopy. One dose of SUFLAVE is equal to one bottle plus one flavor enhancing packet.
Reconstitue each bottle with water before ingestion. Do not reconstitute SUFLAVE with liquids other than water and/or add starch-based thickeners to the mixing bottle

.
Must consume an additional 16 ounces of water after each dose of SUFLAVE.
Consume a low residue breakfast on the day before colonoscopy. After breakfast, only consume clear liquids up to 2 hours prior to colonoscopy.
Do not eat solid food or drink milk or eat or drink anything colored red or purple.
Do not drink alcohol.
Do not take other laxatives while taking SUFLAVE.
.
Do not take oral medications within 1 hour of starting each dose of SUFLAVE.
.
If taking tetracycline or fluoroquinolone antibiotics, iron, digoxin, chlorpromazine, or penicillamine, take these medications at least 2 hours before and not less than 6 hours after administration of each dose of SUFLAVE
.
Stop consumption of all fluids at least 2 hours prior to the colonoscopy.
If nausea, bloating, or abdominal cramping occurs, pause or slow the rate of drinking the solution and additional water until symptoms diminish.
The recommended Split-Dose (two-day) regimen consists of two doses of SUFLAVE:
Day 1, Dose 1: Evening before Colonoscopy: 1 bottle with flavor enhancing packet
Day 2, Dose 2: Morning of the Colonoscopy (5 to 8 hours prior to the colonoscopy and no sooner than 4 hours from starting Dose 1): 1 bottle with flavor enhancing packet
The Day Prior to Colonoscopy:
A low residue breakfast may be consumed. Examples of low residue foods are white bread, biscuits, muffins (no wheat), cornflakes, eggs, cream of wheat, grits, yogurt, cottage cheese, coffee, tea, juice without pulp, fruit (no skin or seeds).
After breakfast, only consume clear liquids until after the colonoscopy. Examples of clear liquids are water, fruit juice (without pulp), lemonade, plain coffee, tea (no cream or non-dairy creamer), chicken broth, gelatin dessert (no fruit or topping).
No red or purple liquids, no milk or alcoholic beverages.
Day 1, Dose 1 - Early in the Evening Prior to Colonoscopy:
Open 1 flavor enhancing packet and pour the contents into 1 bottle.
Fill the provided bottle with lukewarm water up to the fill line. After capping the bottle, gently shake the bottle until all powder has dissolved. For best taste, refrigerate the solution for an hour before drinking. Do not freeze. Use within 24 hours.
Drink 8 ounces of solution every 15 minutes until the bottle is empty.
Drink an additional 16 ounces of water during the evening. …
How to take Magnesium Sulfate and Potassium Sulfate and Sodium Sulfate — instructions & advice from the label
Advise the patient to read the FDA-approved patient labeling (Medication Guide and Instructions for Use).
Instruct patients:
Administration of two doses of SUFLAVE are required for a complete preparation for colonoscopy.
Must reconstitute each bottle with water before ingestion.
Must consume an additional 16 ounces of water after each dose of SUFLAVE.
To hydrate adequately with clear liquids before, during, and after the use of SUFLAVE to prevent dehydration
. Examples of clear liquids can be found in the
Instructions for Use.
If nausea, bloating, or abdominal cramping occurs, pause or slow the rate of drinking the solution and additional water until symptoms diminish.
Do not take other laxatives while taking SUFLAVE.
Do not drink milk or eat or drink anything colored red or purple.
Do not drink alcohol.
Do not take oral medications within one hour of starting each dose of SUFLAVE
.
If taking tetracycline or fluoroquinolone antibiotics, iron, digoxin, chlorpromazine, or penicillamine, take these medications at least 2 hours before and not less than 6 hours after administration of each dose of SUFLAVE
. …
Warnings & precautions
Do not take this medicine if: SUFLAVE is contraindicated in the following conditions:
Gastrointestinal obstruction or ileus
Bowel perforation
Toxic colitis or toxic megacolon
Gastric retention
Hypersensitivity to any ingredient in SUFLAVE

Advise all patients to hydrate adequately before, during, and after the use of SUFLAVE. If a patient develops significant vomiting or signs of dehydration after taking SUFLAVE, consider performing post-colonoscopy lab tests (electrolytes, creatinine, and BUN).
Bowel preparation products can cause fluid and electrolyte disturbances, which can lead to serious adverse reactions including cardiac arrhythmias, seizures, and renal impairment
. Correct fluid and electrolyte abnormalities before treatment with SUFLAVE. Use SUFLAVE with caution in patients with conditions, or who are using medications [such as diuretics, angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs)], that increase the risk for fluid and electrolyte disturbances or may increase the risk of seizure, arrhythmias, and renal impairment
.
There have been rare reports of serious arrhythmias associated with the use of ionic osmotic laxative products for bowel preparation. These occur predominantly in patients with underlying cardiac risk factors and electrolyte disturbances. Use caution when prescribing SUFLAVE for patients at increased risk of arrhythmias (e.g., patients with a history of prolonged QT interval, uncontrolled arrhythmias, recent myocardial infarction, unstable angina, congestive heart failure, or cardiomyopathy). Consider pre-dose and post-colonoscopy ECGs in patients at increased risk of serious cardiac arrhythmias.
There have been reports of generalized tonic-clonic seizures and/or loss of consciousness associated with use of bowel preparation products in patients with no prior history of seizures. …
Magnesium Sulfate and Potassium Sulfate and Sodium Sulfate side effects
The following serious or otherwise important adverse reactions for bowel preparations are described elsewhere in the labeling:
Serious Fluid and Electrolyte Abnormalities
Cardiac Arrhythmias
Seizures
Patients with Risk of Renal Injury
Colonic Mucosal Ulceration and Ischemic Colitis
Patients with Significant Gastrointestinal Disease
Aspiration
Hypersensitivity Reactions
Because clinical studies are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in clinical trials of another drug and may not reflect the rates observed in practice.
The safety of SUFLAVE was evaluated in two randomized, parallel group, multicenter, investigator-blinded clinical trials in 929 adult patients undergoing colonoscopy. The active comparators were polyethylene glycol 3350, sodium sulfate, sodium chloride, potassium chloride, ascorbic acid and sodium ascorbate for oral solution in Study 1 and sodium sulfate, potassium sulfate, and magnesium sulfate oral solution in Study 2
.
Table 1 shows the most common adverse reactions reported in at least 2% of patients in either treatment group in Study 1.
aReported in at least 2% of patients in either treatment group.
bStudy 1 was not designed to support comparative claims for SUFLAVE for the adverse reactions reported in this table.
cAbdominal pain is composed of several similar terms. …
Drug interactions
Use caution when prescribing SUFLAVE to patients taking medications that increase the risk of fluid and electrolyte disturbances or may increase the risk of adverse events of seizure, arrhythmias, and prolonged QT in the setting of fluid and electrolyte abnormalities
.
SUFLAVE can reduce the absorption of other co-administered drugs
:
Administer oral medications at least one hour before starting each dose of SUFLAVE.
Administer tetracycline and fluoroquinolone antibiotics, iron, digoxin, chlorpromazine, and penicillamine at least 2 hours before and not less than 6 hours after administration of each dose of SUFLAVE to avoid chelation with magnesium.
Concurrent use of stimulant laxatives and SUFLAVE may increase the risk of mucosal ulceration or ischemic colitis. Avoid use of stimulant laxatives (e.g., bisacodyl, sodium picosulfate) while taking SUFLAVE
.
About this medicine
SUFLAVE (polyethylene glycol 3350, sodium sulfate, potassium chloride, magnesium sulfate, and sodium chloride for oral solution) is an osmotic laxative and is provided in two bottles and two flavor enhancing packets for oral solution.
The active ingredients contained in SUFLAVE are provided in Table 3.
Chemical Name | Chemical Formula | Average Molecular
Weight (g/mol) | Chemical Structure
Polyethlyene Glycol
3350, USP | 3350
Sodium Sulfate, USP | Na
2SO
4 | 142.04
Magnesium Sulfate, USP | MgSO
4 | 120.37
Potassium Chloride, USP | KCl | 74.55
Sodium Chloride, USP | NaCl | 58.44 | Na
+Cl
-
Each bottle contains 178.7 g polyethylene glycol 3350, 7.3 g sodium sulfate, 1.12 g potassium chloride, 0.9 g magnesium sulfate, and 0.5 g sodium chloride, plus the following excipients: advantame, lemon-lime flavor, and neotame.
Each flavor enhancing packet contains anhydrous citric acid, colloidal silicon dioxide, malic acid, and sucralose. …
Source: FDA-approved label via DailyMed (U.S. National Library of Medicine), label set ID 546cfc44-791c-4524-99a9-6a0af96c4ec8. Read the full official label on DailyMed.